Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 3/2012

01.06.2012 | Research Article

Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria

verfasst von: Rosa Lemmens-Gruber, Christine Hahnenkamp, Ulrike Gössmann, Jürgen Harreiter, Majid-Reza Kamyar, Barbara Julienne Johnson, Steve Hudson, Alexandra Kautzky-Willer

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Background Effective control of diabetes mellitus type 1 (DM1) and type 2 (DM2) can reduce the development and progression of diabetic complications. Therefore, patient education should be considered as an integral part of diabetes management. Objective The aim of the study was to assess DM patients’ perception of knowledge for their medication and attitude towards self-management and pharmacist’s role. Setting The study was conducted at the diabetes out-patient clinic at the Vienna General Hospital (AKH), Division of Endocrinology and Metabolism, Department of Internal Medicine III, Austria. Method The study was a cross sectional survey using patient data from a validated patient questionnaire and medical records. Medical records were evaluated by applying a medication assessment tool. Main outcome measure To assess the quality of diabetes self management the following outcome measures are considered: HbA1c levels, pre- and post-prandial blood glucose levels, prevention of acute episodes of hypo- and hyperglycaemia, reduction of macrovascular risk factors, short term quality of life, adverse effects and treatment tolerance. Results The present study comprised 225 patients with DM1 and 201 patients with DM2, respectively. In comparison to DM2 patients, cardio- and cerebrovascular diseases were diagnosed very rarely in patients with DM1. The risk for these diseases was higher in patients with other factors of the metabolic syndrome, in addition. Overall, 118 of these patients participated in the questionnaire. The level of positive response on diabetes self-care and knowledge with respect to medication for the prevention of diabetes complications, glycaemic control, and treatment goals in diabetes was 81.8 %. The comparison of patients’ perceptions of diabetes self-care and knowledge showed differences among subgroups. Higher perceived knowledge and self-care apparently was associated with DM1. Additional findings of this study indicate that patients do not expect community pharmacists to be integrated in a multidisciplinary diabetes care team. Conclusion Although the level of positive response was found to be high there is still a minority of patients whose level of comprehension appears to be insufficient. Intense pharmaceutical care including patients’ education within a multidisciplinary team could contribute to improvements in those patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Dorner T, Rathmanner T, Lechleitner M, Schlögel R, Roden M, Lawrence K, et al. Public health aspects of diabetes mellitus-epidemiology, prevention strategies, policy implications: the first Austrian diabetes report. Wien Klin Wochenschr. 2006;118:513–9.PubMedCrossRef Dorner T, Rathmanner T, Lechleitner M, Schlögel R, Roden M, Lawrence K, et al. Public health aspects of diabetes mellitus-epidemiology, prevention strategies, policy implications: the first Austrian diabetes report. Wien Klin Wochenschr. 2006;118:513–9.PubMedCrossRef
3.
Zurück zum Zitat Walker R, Whittlesea C. Clinical pharmacy and therapeutics. 4th Edition, Edinburgh, New York: Churchill Livingstone; 2007. ISBN 9780443102851. Walker R, Whittlesea C. Clinical pharmacy and therapeutics. 4th Edition, Edinburgh, New York: Churchill Livingstone; 2007. ISBN 9780443102851.
4.
Zurück zum Zitat National Institute for Clinical Excellence. (NICE Clinical Guideline 87) Type 2 diabetes. The management of type 2 diabetes. London: NICE; 2009. Accessed 1 Feb 2012. National Institute for Clinical Excellence. (NICE Clinical Guideline 87) Type 2 diabetes. The management of type 2 diabetes. London: NICE; 2009. Accessed 1 Feb 2012.
5.
Zurück zum Zitat Wermeille J, Bennie M, Brown I, McKnight J. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team—a pilot study. Pharm World Sci. 2004;26:18–25.PubMedCrossRef Wermeille J, Bennie M, Brown I, McKnight J. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team—a pilot study. Pharm World Sci. 2004;26:18–25.PubMedCrossRef
6.
Zurück zum Zitat Deakin T, McShane CE, Cade JE, Williams RDRR. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;2: CD003417. Deakin T, McShane CE, Cade JE, Williams RDRR. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;2: CD003417.
7.
Zurück zum Zitat Renders CM, Valk GD, Griffin SJ, Wagner EH, Van Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient and community settings: a systematic review. Diabetes Care. 2001;24:1821–33.PubMedCrossRef Renders CM, Valk GD, Griffin SJ, Wagner EH, Van Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient and community settings: a systematic review. Diabetes Care. 2001;24:1821–33.PubMedCrossRef
8.
Zurück zum Zitat Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25:1159–71.PubMedCrossRef Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25:1159–71.PubMedCrossRef
9.
Zurück zum Zitat Burgers JS, Bailey JV, Klazinga NS, Van Der Bij AK, Grol R, Feder G. AGREE collaboration. Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care. 2002;25:1933–9.PubMedCrossRef Burgers JS, Bailey JV, Klazinga NS, Van Der Bij AK, Grol R, Feder G. AGREE collaboration. Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care. 2002;25:1933–9.PubMedCrossRef
11.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32:1514–22. American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32:1514–22.
12.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
13.
Zurück zum Zitat UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J. 1998;317:703–13.CrossRef UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J. 1998;317:703–13.CrossRef
14.
Zurück zum Zitat National Institute for Health and Clinical Excellence. (NICE Technology Appraisal 60) Guidance on the use of patient-education models for diabetes. London: NICE; 2003. Accessed 2009. National Institute for Health and Clinical Excellence. (NICE Technology Appraisal 60) Guidance on the use of patient-education models for diabetes. London: NICE; 2003. Accessed 2009.
16.
Zurück zum Zitat Power A, McKellar S, Hudson S. A consensus model for delivery of structured pharmaceutical care for the patients with type 2 diabetes mellitus by Scottish community pharmacists. Int J Pharm Pract. 2007;15:255–7.CrossRef Power A, McKellar S, Hudson S. A consensus model for delivery of structured pharmaceutical care for the patients with type 2 diabetes mellitus by Scottish community pharmacists. Int J Pharm Pract. 2007;15:255–7.CrossRef
17.
Zurück zum Zitat Kamyar MR, Johnson BJ, McAnaw JJ, Lemmens-Gruber R, Hudson SA. Evaluation of the implementation of medication guidelines in the prevention of coronary heart disease for patients with type II diabetes mellitus in primary care. Pharm World Sci. 2008;30:120–7.PubMedCrossRef Kamyar MR, Johnson BJ, McAnaw JJ, Lemmens-Gruber R, Hudson SA. Evaluation of the implementation of medication guidelines in the prevention of coronary heart disease for patients with type II diabetes mellitus in primary care. Pharm World Sci. 2008;30:120–7.PubMedCrossRef
18.
Zurück zum Zitat Ernst A, Kinnear M, Hudson S. Quality of prescribing: a study of guideline adherence of medication in patients with diabetes mellitus. Prac Diab Int. 2005;22:285–90.CrossRef Ernst A, Kinnear M, Hudson S. Quality of prescribing: a study of guideline adherence of medication in patients with diabetes mellitus. Prac Diab Int. 2005;22:285–90.CrossRef
21.
Zurück zum Zitat McAnaw J, Hudson S, McGlynn S. Development of an evidence-based medication assessment tool to demonstrate the quality of drug therapy use in patients with heart failure. Int J Pharm Pract. 2003;11:R17. McAnaw J, Hudson S, McGlynn S. Development of an evidence-based medication assessment tool to demonstrate the quality of drug therapy use in patients with heart failure. Int J Pharm Pract. 2003;11:R17.
22.
Zurück zum Zitat Korsatko S, Habacher W, Rakovac I, Plank J, Seereiner S, Beck P, et al. Evaluation of a teaching and treatment program in more than 4,000 type 2 diabetic patients after introduction of reimbursement policy for physicians. Diabetes Care. 2007;30:1584–6.PubMedCrossRef Korsatko S, Habacher W, Rakovac I, Plank J, Seereiner S, Beck P, et al. Evaluation of a teaching and treatment program in more than 4,000 type 2 diabetic patients after introduction of reimbursement policy for physicians. Diabetes Care. 2007;30:1584–6.PubMedCrossRef
23.
Zurück zum Zitat Kautzky-Willer A, Kamyar MR, Gerhat D, Handisurya A, Stemer G, Hudson S, et al. Sex-specific differences in metabolic control and cardiovascular risk in patients with type 2 diabetes. Gend Med. 2010;7:571–83.PubMedCrossRef Kautzky-Willer A, Kamyar MR, Gerhat D, Handisurya A, Stemer G, Hudson S, et al. Sex-specific differences in metabolic control and cardiovascular risk in patients with type 2 diabetes. Gend Med. 2010;7:571–83.PubMedCrossRef
24.
Zurück zum Zitat Al-Qazaz HK, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-Nuri R, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33(6):1028–35.PubMedCrossRef Al-Qazaz HK, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-Nuri R, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33(6):1028–35.PubMedCrossRef
25.
Zurück zum Zitat Al-Adsani A, Moussa M, Al-Jasem L, Abdella N, Al-Hamad N. The level and determinants of diabetes knowledge in Kuwaiti adults with type 2 diabetes. Diabetes Metab. 2009;35(2):121–8.PubMedCrossRef Al-Adsani A, Moussa M, Al-Jasem L, Abdella N, Al-Hamad N. The level and determinants of diabetes knowledge in Kuwaiti adults with type 2 diabetes. Diabetes Metab. 2009;35(2):121–8.PubMedCrossRef
26.
Zurück zum Zitat Berikai P, Meyer P, Kazlauskaite R, Savoy B, Kozik K, Fogelfeld L. Gain in patients‘knowledge of diabetes management targets is associated with better glycemic control. Diabetes Care. 2007;30(6):1587–9.PubMedCrossRef Berikai P, Meyer P, Kazlauskaite R, Savoy B, Kozik K, Fogelfeld L. Gain in patients‘knowledge of diabetes management targets is associated with better glycemic control. Diabetes Care. 2007;30(6):1587–9.PubMedCrossRef
27.
Zurück zum Zitat He X, Wharrad H. Diabetes knowledge and glycemic control among Chinese people with type 2 diabetes. Int Nurs Rev. 2007;54(3):280–7.PubMedCrossRef He X, Wharrad H. Diabetes knowledge and glycemic control among Chinese people with type 2 diabetes. Int Nurs Rev. 2007;54(3):280–7.PubMedCrossRef
28.
Zurück zum Zitat Tan M, Magarey J. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control. Patient Educ Couns. 2008;72(2):252–67.PubMedCrossRef Tan M, Magarey J. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control. Patient Educ Couns. 2008;72(2):252–67.PubMedCrossRef
29.
Zurück zum Zitat McGowan N, Cockburn A, Strachan MW, Padfield PL, McKnight JA. Initial and sustained cardiovascular risk reduction in a pharmacist-led diabetes cardiovascular risk clinic. Br J Diabetes Vasc Dis. 2008;8:34–8.CrossRef McGowan N, Cockburn A, Strachan MW, Padfield PL, McKnight JA. Initial and sustained cardiovascular risk reduction in a pharmacist-led diabetes cardiovascular risk clinic. Br J Diabetes Vasc Dis. 2008;8:34–8.CrossRef
30.
Zurück zum Zitat Lowey A, Moore S, Norris C, Wright D, Silcock J, Hammond P. The cost-effectiveness of pharmacist-led treatment of cardiac risk in patient with type 2 diabetes. Pharm World Sci. 2007;29:541–5.PubMedCrossRef Lowey A, Moore S, Norris C, Wright D, Silcock J, Hammond P. The cost-effectiveness of pharmacist-led treatment of cardiac risk in patient with type 2 diabetes. Pharm World Sci. 2007;29:541–5.PubMedCrossRef
31.
Zurück zum Zitat Blenkinsopp A, Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract. 2005;13(4):231–40.CrossRef Blenkinsopp A, Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract. 2005;13(4):231–40.CrossRef
32.
Zurück zum Zitat Bissell P, Blenkinsopp A, Short D, Mason L. Patients’ experiences of a community pharmacy-led medicines management service. Health Soc Care Commun. 2008;16(4):363–9.CrossRef Bissell P, Blenkinsopp A, Short D, Mason L. Patients’ experiences of a community pharmacy-led medicines management service. Health Soc Care Commun. 2008;16(4):363–9.CrossRef
33.
Zurück zum Zitat Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother. 2007;41(12):1962–70.PubMedCrossRef Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother. 2007;41(12):1962–70.PubMedCrossRef
Metadaten
Titel
Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria
verfasst von
Rosa Lemmens-Gruber
Christine Hahnenkamp
Ulrike Gössmann
Jürgen Harreiter
Majid-Reza Kamyar
Barbara Julienne Johnson
Steve Hudson
Alexandra Kautzky-Willer
Publikationsdatum
01.06.2012
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 3/2012
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9636-0

Weitere Artikel der Ausgabe 3/2012

International Journal of Clinical Pharmacy 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.